Clinical study paper on TMR therapy with autologous stem cells presented PLC Systems Inc. , a ongoing company centered on innovative cardiac and vascular medical device-based technologies, today announced a paper on a scientific research making use of its Transmyocardial Laser Revascularization therapy in conjunction with autologous stem cells was offered at ESC Congress 2009, the annual conference of the European Culture of Cardiology, in Barcelona, Spain. This research is made to examine the security and feasibility of transplanting stem cells during TMR found in combination with coronary bypass grafting in patients with end-stage heart failing http://l-e-v-i-t-r-a.com .
5 years post-treatment, I stay cancer-free with my standard of living completely intact. .. Clinical study results of prostate cancer individuals treated with CyberKnife Radiosurgery released Accuray Incorporated , a worldwide leader in the field of radiosurgery, announced today publication of outcomes from a scholarly research of early stage prostate malignancy individuals treated with CyberKnife Radiosurgery. The study demonstrated that erectile function was preserved in 81 % of individuals at a median follow-up of two years. Published rates of erectile function preservation at two years for other generally used prostate cancer remedies, such as for example open surgery and regular radiation therapy, range between 50-70 %.